Sphera Funds Management Ltd. 13F holdings, Q1 2026
Holdings as of March 31, 2026 · filings on SEC EDGAR · latest filing →
Sphera Funds Management Ltd. disclosed 92 US equity positions worth $581.5m in its Q1 2026 13F filing. The largest position was MLYS at 6.2% of the reported book, followed by TEVA and TSEM.
What did Sphera Funds Management Ltd. own in Q1 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 6.2% | $36.3m | 1,339,971 | – | |
| 2 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 5.9% | $34.2m | 1,136,975 | – | |
| 3 | TSEM TOWER SEMICONDUCTOR LTD | Technology | 4.4% | $25.6m | 145,735 | – | |
| 4 | NVMI NOVA LTD | Technology | 4.0% | $23.2m | 53,366 | – | |
| 5 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 3.1% | $18.2m | 245,246 | – | |
| 6 | BIIB BIOGEN INC | Healthcare | 2.9% | $17.0m | 92,526 | – | |
| 7 | RARE ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 2.9% | $17.0m | 809,333 | – | |
| 8 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 2.9% | $16.9m | 724,563 | – | |
| 9 | COGT COGENT BIOSCIENCES INC | Healthcare | 2.8% | $16.0m | 416,340 | – | |
| 10 | SNY SANOFI SA | Healthcare | 2.2% | $13.0m | 269,515 | – | |
| 11 | AZN ASTRAZENECA PLC | Healthcare | 2.1% | $12.3m | 62,530 | – | |
| 12 | AM6 AMICUS THERAPEUTIC | 1.5% | $8.7m | 603,377 | – | ||
| 13 | CLBT CELLEBRITE DI LTD | Technology | 1.5% | $8.7m | 631,521 | – | |
| 14 | APLSUSD APELLIS PHARMACEUTICALS INC | 1.5% | $8.6m | 214,914 | – | ||
| 15 | PANW PALO ALTO NETWORKS INC | Technology | 1.5% | $8.5m | 52,800 | – | |
| 16 | LLY ELI LILLY & CO | Healthcare | 1.4% | $8.3m | 9,040 | – | |
| 17 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.4% | $8.2m | 866,464 | – | |
| 18 | CAMT CAMTEK LTD | Technology | 1.4% | $8.0m | 53,020 | – | |
| 19 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 1.4% | $7.9m | 139,900 | – | |
| 20 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.3% | $7.7m | 243,575 | – | |
| 21 | ORA ORMAT TECHNOLOGIES INC | Utilities | 1.3% | $7.6m | 68,250 | – | |
| 22 | XENE XENON PHARMACEUTICALS INC | Healthcare | 1.3% | $7.4m | 127,000 | – | |
| 23 | SLNOEUR SOLENO THERAPEUTICS INC | 1.2% | $7.2m | 216,281 | – | ||
| 24 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.2% | $7.2m | 343,563 | – | |
| 25 | JNJ JOHNSON & JOHNSON | Healthcare | 1.2% | $7.0m | 28,831 | – | |
| 26 | SOLAREDGE TECHNOLOGIES INC | 1.2% | $6.9m | 4,000,000 | – | ||
| 27 | IMTX IMMATICS N.V | Healthcare | 1.2% | $6.8m | 696,105 | – | |
| 28 | TRVI TREVI THERAPEUTICS INC | Healthcare | 1.2% | $6.8m | 574,029 | – | |
| 29 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 1.2% | $6.8m | 537,628 | – | |
| 30 | MAZE MAZE THERAPEUTICS INC | Healthcare | 1.2% | $6.8m | 227,343 | – | |
| 31 | GSK GSK PLC | Healthcare | 1.2% | $6.7m | 122,000 | – | |
| 32 | AMZN AMAZON COM INC | Consumer Cyclical | 1.1% | $6.7m | 31,940 | – | |
| 33 | ABBV ABBVIE INC | Healthcare | 1.1% | $6.6m | 30,256 | – | |
| 34 | AAOI APPLIED OPTOELECTRONICS INC | Technology | 1.1% | $6.2m | 73,400 | – | |
| 35 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 1.0% | $6.0m | 153,265 | – | |
| 36 | MRK MERCK & CO INC | Healthcare | 1.0% | $5.8m | 48,600 | – | |
| 37 | VOR VOR BIOPHARMA INC | Healthcare | 1.0% | $5.7m | 321,917 | – | |
| 38 | ACAD ACADIA PHARMACEUTICALS INC | Healthcare | 1.0% | $5.7m | 256,202 | – | |
| 39 | NVS NOVARTIS AG | Healthcare | 1.0% | $5.7m | 37,000 | – | |
| 40 | ELDN ELEDON PHARMACEUTICALS INC | 0.9% | $5.5m | 1,772,131 | – | ||
| 41 | ENPH ENPHASE ENERGY INC | Technology | 0.9% | $5.4m | 142,419 | – | |
| 42 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.9% | $5.4m | 55,110 | – | |
| 43 | PFE PFIZER INC | Healthcare | 0.9% | $5.2m | 186,000 | – | |
| 44 | BHVN BIOHAVEN LTD | Healthcare | 0.9% | $5.0m | 594,000 | – | |
| 45 | FBRX FORTE BIOSCIENCES INC | 0.8% | $4.8m | 184,984 | – | ||
| 46 | HELP CYBIN INC | 0.8% | $4.7m | 987,090 | – | ||
| 47 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 0.8% | $4.7m | 9,040 | – | |
| 48 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.8% | $4.6m | 94,265 | – | |
| 49 | NVO NOVO-NORDISK A S | Healthcare | 0.8% | $4.4m | 120,677 | – | |
| 50 | MDWD MEDIWOUND LTD | Healthcare | 0.8% | $4.4m | 273,192 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.